Bio-IT World, Boston, MA, March 13, 2002, 6:00PM – 7:30PM
Discussion Moderator: Bernard P. Wess, President
Summary:
No industry integrates more
complex information than the Life Sciences.
From units of organization ranging from the molecular, to the document,
to the family unit and, ultimately, country and government; Life Sciences
companies generate enormous numbers of documents and amounts of data. Market information, regulatory
documentation, disease management, clinical trials, detailed research and
development and finally, medical records and claims data and documents must all
be integrated to improve the clinical efficacy and financial performance of a
new pharmaceutical for a specific target market and patient population. With the fully burdened costs of new
pharmaceutical development approaching $800 million data and document
integration affects speed-to-market and shareholder value.
According to
PricewaterhouseCoopers, full data integration, from passive repositories to
active repositories of data and documents will facilitate:
Better compliance and faster
regulatory approval
Creating a management
environment of flexible and adaptive decision making by utilizing scenario
planning
Using predictive market
modeling and simulation to develop small market segments, new pharmaceuticals
and devices
Monitoring a global
“e-environment” of markets, research and development
Tracking and documenting
emerging trends and competitive threats
Better allocations of
internal and partner resources
Adaptive experimentation in
marketing, i.e., electronic CRM for patients
Real-time management review
and iteration of decisions
Consider:
What is your view of how to
succeed at Data Integration?
Where
do/did you start?
How
is your organization planning to integrate data?
What
are your needs in terms of technology and skills?
What
is your goal?